WASHINGTON, DC
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)FOUNDATION FOR BIOMEDICAL RESEARCH, founded in 1981, is a community nonprofit in the Medical Research sector that reported $1.9M in total revenue in fiscal year 2025. Revenue grew 19% year-over-year, indicating healthy expansion. The organization ran a surplus of $726K, a strong 38% operating margin.
CREATE AND DISSEMINATE EDUCATIONAL MATERIALS TO THE GENERAL PUBLIC, THE MEDIA, STUDENTS, AND THE RESEARCH COMMUNITY THAT DESCRIBES THE ESSENTIAL ROLE HUMANE AND RESPONSIBLE ANIMAL RESEARCH PLAYS IN CONTINUED MEDICAL PROGRESS.
MEDIA AND PUBLIC RELATIONS - THE FOUNDATION SERVES AS A SPOKESPERSON FOR THE COMMUNITY ON ANIMAL RESEARCH BY PROMOTING A PUBLIC UNDERSTANDING THROUGH VARIOUS MEDIA OUTLETS.
JOURNALS AND PAMPHLETS-THE FOUNDATION PUBLISHES VARIOUS JOURNALS AND PAMPHLETS DESIGNED TO EDUCATE PEOPLE AS TO THE BENEFITS PROVIDED BY BIOMEDICAL RESEARCH. PREPARES MATERIALS TO DISSEMINATE...
JOURNALS AND PAMPHLETS-THE FOUNDATION PUBLISHES VARIOUS JOURNALS AND PAMPHLETS DESIGNED TO EDUCATE PEOPLE AS TO THE BENEFITS PROVIDED BY BIOMEDICAL RESEARCH. PREPARES MATERIALS TO DISSEMINATE INFORMATION REGARDING ROLE OF BIOMEDICAL RESEARCH TO THE SCIENTIFIC COMMUNITY.
TRAVEL & MEETINGS-THE FOUNDATION PROMOTES THE IMPORTANCE OF BIOMEDICAL RESEARCH BY ATTENDING MEETINGS & CONVENTIONS WHERE THEY SPEAK ABOUT ISSUES RELATED TO SUCH RESEARCH.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2025 | 2024 | Change | |
|---|---|---|---|
| Revenue | $1,931,597 | $1,620,680 | +0.2% |
| Expenses | $1,205,880 | $1,169,579 | +0.0% |
| Net Income | $725,717 | $451,101 | +0.6% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| JAMES ALLAN | CHAIR | 2.00 |
Director
|
$0 | $0 | $0 |
| LENORE COONEY | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| HENRY FRIEDMAN | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| SUE VANDEWOUDE | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| CORINNA BEALE | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| JOANNE KUTZBERG | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| JOHN E NIEDERHUBER | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| ARTHUR RUBENSTEIN | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| CAROL SCHEMAN | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| OSWALD STEWARD | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| SUZANNA GREER | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| ELENA FUENTES-AFFLICK | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| AMY CIANCIARUSO | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| MATTHEW BAILEY | PRESIDENT | 20.00 |
Officer
|
$199,375 | $0 | $199,375 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $1,931,597 | $1,205,880 | $23,139,155 | $725,717 |
| 2024 | No data | No data | No data | No data |
| 2023 | $1,120,386 | $1,130,086 | $19,618,159 | $-9,700 |
| 2022 | $3,400,871 | $896,468 | $17,068,301 | $2,504,403 |
| 2021 | $1,890,553 | $1,099,178 | $19,886,643 | $791,375 |
| 2020 | $1,151,174 | $1,126,322 | $17,664,992 | $24,852 |
| 2019 | $3,176,496 | $1,102,927 | $16,658,304 | $2,073,569 |
| 2018 | $1,482,175 | $967,047 | $14,303,004 | $515,128 |
Compare FOUNDATION FOR BIOMEDICAL RESEARCH with other nonprofits in District of Columbia and across the country.